Nikou Gougol, MD
Internal Medicine · Brooklyn
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Interfaith Professional Physician Services PC · 383 clinicians in this group
Hospitals listed: Brookdale Hospital Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gougol’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Brookdale Hospital Medical CenterBrooklyn, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Brookdale University Hospital And Medical CenterPatients rate it 1 of 5 · 42% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.51 (1.14 to 1.88), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.19 (1.55 to 2.83) · 3,663 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.1, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.196, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Brookdale Hospital Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 3 better, 2 the same, 1 worse of 6 measures. Readmissions: 0 better, 5 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.51 (1.14 to 1.88) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.19 (1.55 to 2.83) · 3,663 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.1 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.196 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 720 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.88 (168.25 to 277.5) · 40 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.2 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.6 · 195 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.2 · 417 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 3,100 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.01 to 0.43) · 4,158 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,249 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.69 (1.3 to 6.07) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.97 (0.38 to 3.57) · 526 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.76 (1.24 to 20.28) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.91 (1.66 to 10.15) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.05 (0.54 to 3.55) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 47 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.965 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 149 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 25 · 560 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 150 · 150 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -16.9 · 163 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 521 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 22.8 · 436 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.7 (10.9 to 19.8) · 157 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 45 cases | No different | Jan 2024 – Dec 2024 |
What patients said (958 patients answered, 8% of those asked)
| Cleanliness | 2 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 1 |
| Quietness | 2 |
| Recommend hospital | 1 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 64% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 51% |
| Yes, staff "did" give patients this information | 73% |
| Yes, staff "did" give patients information about help after discharge | 71% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 73% |
| Patients who gave a rating of "9" or "10" (high) | 44% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 61% |
| Nurses "always" treated them with courtesy and respect | 71% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 42% |
| Staff "always" explained possible side effects | 37% |
| Yes, staff "did" give patients information about possible symptoms | 74% |
Original Medicare doctor bills
$10,197
Medicare paid this office $10,197 for 66 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 30 | $4,566 | $83 |
| Return visit (30+ min) | 12 | $1,872 | $75 |
| Short return visit (20+ min) | 15 | $855 | $45 |
Who their Medicare patients are
66 Original Medicare patients in 2024. Average age 71 · Women 52% · Also on Medicaid 67% · Health risk score 1.39. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 23% · Chronic kidney disease 23% · Depression 21% · Heart failure 17% · Stroke 17%.
The office billed $42,929, Medicare allowed $14,368 and paid $10,197; for 134 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 66 | 134 | 71 | 1.39 | $42,929 | $10,197 |
| 2023 | 42 | 64 | 68 | 1.51 | $13,881 | $4,936 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 18 | $2,161 | $94 |
| Short return visit (20+ min) | 17 | $1,636 | $68 |
| Short return visit | 13 | $668 | $48 |
Medicaid work
$50,844 in 2024
Medicaid paid $50,844 for 3,091 billed services this clinician did in 2024, up to 50 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 582 | $32,912 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 1,072 | $8,471 |
| Short return visit (20+ min) | 123 | $7,031 |
| New patient visit (45+ min) | 12 | $1,564 |
| Short return visit | 17 | $567 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 250 | $242 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 88 | $25 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 54 | $18 |
| Pain severity quantified; pain present (COA) (ONC) | 75 | $7 |
| TOBACCO NON-USER | 208 | $2 |
| Medication list documented in medical record (COA) | 298 | $2 |
| BODY MASS INDEX DOCD | 257 | $2 |
| 2024 | 3,091 | 14 | 50 | $50,844 |
| 2023 | 1,844 | 19 | 49 | $27,501 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 193 | $11,455 |
| Return visit (30+ min) | 94 | $8,169 |
| New patient visit (45+ min) | 28 | $3,684 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 162 | $2,047 |
| Short return visit | 50 | $1,981 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 93 | $70 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 83 | $63 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 41 | $33 |
| Current tobacco smoker (CAD, CAP, COPD, PV) (DM) | 12 | $0 |
| TOBACCO NON-USER | 184 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 86 | $0 |
| Medication list documented in medical record (COA) | 268 | $0 |
Drugs they prescribed that Part D paid
$1,057,363
Pharmacies billed $1,057,363 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 5,459) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
4,161 generic and 1,003 brand-name prescriptions · $1,057,363 in drug cost · 51 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac | 171 | $203,607 | $1,191 |
| Ozempic | 126 | $133,830 | $1,062 |
| Jardiance | 114 | $93,712 | $822 |
| Metformin Er Gastric | 66 | $82,971 | $1,257 |
| Mounjaro | 58 | $59,428 | $1,025 |
See all 91 drugs
| Diclofenac | 171 | $203,607 | $1,191 |
| Ozempic | 126 | $133,830 | $1,062 |
| Jardiance | 114 | $93,712 | $822 |
| Metformin Er Gastric | 66 | $82,971 | $1,257 |
| Mounjaro | 58 | $59,428 | $1,025 |
| Eliquis | 57 | $41,356 | $726 |
| Trulicity | 25 | $38,363 | $1,535 |
| Farxiga | 45 | $31,730 | $705 |
| Entresto | 43 | $30,850 | $717 |
| Januvia | 39 | $30,772 | $789 |
| Xarelto | 34 | $24,215 | $712 |
| Rybelsus | 22 | $23,981 | $1,090 |
| Oxiconazole Nitrate | 65 | $21,712 | $334 |
| Lactulose | 23 | $21,198 | $922 |
| Janumet | 17 | $15,170 | $892 |
| Tavaborole | 70 | $13,276 | $190 |
| Basaglar Kwikpen U-100 | 42 | $13,262 | $316 |
| Tradjenta | 11 | $8,908 | $810 |
| Amlodipine-Atorvastatin | 51 | $8,526 | $167 |
| Vascepa | 17 | $5,554 | $327 |
| Incruse Ellipta | 15 | $5,547 | $370 |
| Meloxicam | 11 | $4,909 | $446 |
| Atorvastatin | 407 | $3,846 | $9 |
| Lidocaine | 29 | $3,699 | $128 |
| Albuterol Sulfate Hfa | 112 | $3,016 | $27 |
| Novolog Flexpen | 19 | $2,762 | $145 |
| Symbicort | 11 | $2,630 | $239 |
| Budesonide-Formoterol | 17 | $2,386 | $140 |
| Lantus Solostar | 28 | $2,349 | $84 |
| Mesalamine Er | 12 | $2,199 | $183 |
| Losartan | 231 | $2,122 | $9 |
| Amlodipine Besylate | 358 | $2,101 | $6 |
| Alcohol Prep Pads | 102 | $1,764 | $17 |
| Nifedipine Er | 87 | $1,703 | $20 |
| Metoprolol | 116 | $1,351 | $12 |
| Ultra-Fine Mini Pen Needle | 22 | $1,266 | $58 |
| Enalapril Maleate | 64 | $1,216 | $19 |
| Ultra-Fine Nano Pen Needle | 21 | $1,207 | $57 |
| Gabapentin | 131 | $1,186 | $9 |
| Tamsulosin | 73 | $1,162 | $16 |
| Labetalol | 32 | $1,098 | $34 |
| Rosuvastatin | 82 | $921 | $11 |
| Valsartan | 39 | $919 | $24 |
| Alendronate | 133 | $864 | $6 |
| Ammonium Lactate | 38 | $859 | $23 |
| Metformin | 149 | $806 | $5 |
| Metformin Hcl Er | 111 | $779 | $7 |
| Alcohol Pads | 21 | $696 | $33 |
| Duloxetine | 21 | $694 | $33 |
| Ulticare Pen Needle | 11 | $601 | $55 |
| Carvedilol | 89 | $584 | $7 |
| Amlodipine-Valsartan | 20 | $546 | $27 |
| Famotidine | 74 | $543 | $7 |
| Chlorthalidone | 30 | $514 | $17 |
| Mirtazapine | 28 | $482 | $17 |
| Pravastatin | 43 | $462 | $11 |
| Pantoprazole | 72 | $416 | $6 |
| Clopidogrel | 47 | $394 | $8 |
| Mometasone Furoate | 18 | $355 | $20 |
| Hydrochlorothiazide | 82 | $342 | $4 |
| Ezetimibe | 17 | $337 | $20 |
| Omeprazole | 42 | $284 | $7 |
| Losartan-Hydrochlorothiazide | 29 | $275 | $9 |
| Montelukast | 33 | $266 | $8 |
| Amlodipine Besylate-Benazepril | 22 | $265 | $12 |
| Ketoconazole | 18 | $247 | $14 |
| Finasteride | 22 | $234 | $11 |
| Clotrimazole | 12 | $225 | $19 |
| Levothyroxine | 19 | $219 | $12 |
| Benazepril | 34 | $179 | $5 |
| Meclizine | 28 | $170 | $6 |
| Fluticasone Propionate | 19 | $163 | $9 |
| Ibandronate | 12 | $149 | $12 |
| Lisinopril | 24 | $140 | $6 |
| Baclofen | 11 | $133 | $12 |
| Trazodone | 18 | $127 | $7 |
| Latanoprost | 17 | $120 | $7 |
| Doxazosin Mesylate | 12 | $118 | $10 |
| Metoprolol | 16 | $105 | $7 |
| Easy Touch Alcohol Prep Pads | 31 | $99 | $3 |
| Simvastatin | 17 | $92 | $5 |
| Furosemide | 39 | $85 | $2 |
| Azithromycin | 21 | $72 | $3 |
| Single Use Swab | 24 | $71 | $3 |
| Cyclobenzaprine | 28 | $66 | $2 |
| Hydrocortisone | 13 | $62 | $5 |
| Vitamin D2 | 40 | $51 | $1 |
| Topiramate | 11 | $46 | $4 |
| Ibuprofen | 21 | $43 | $2 |
| Naproxen | 12 | $23 | $2 |
| Warfarin | 11 | $20 | $2 |
Year by year
| 2024 | 5,459 | 421 | 0% (0) | 18% | $1,057,363 |
| 2023 | 1,488 | 278 | None | 18% | $241,823 |
| 2022 | 167 | 41 | 0% (0) | None | $22,291 |
| 2021 | 37 | 14 | 0% (0) | None | $3,129 |
| 2020 | 152 | 44 | None | 17% | $12,840 |
| 2019 | 103 | 29 | 0% (0) | 20% | $6,017 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Ozempic | 26 | $28,763 | $1,106 |
| Janumet | 11 | $17,119 | $1,556 |
| Jardiance | 13 | $14,554 | $1,120 |
| Diclofenac | 21 | $10,859 | $517 |
| Symbicort | 12 | $7,034 | $586 |
| Basaglar Kwikpen U-100 | 16 | $5,237 | $327 |
| Lantus Solostar | 11 | $4,138 | $376 |
| Oxiconazole Nitrate | 12 | $3,653 | $304 |
| Atorvastatin | 112 | $2,261 | $20 |
| Duloxetine | 12 | $1,390 | $116 |
| Losartan | 56 | $1,181 | $21 |
| Amlodipine Besylate | 105 | $897 | $9 |
| Albuterol Sulfate Hfa | 24 | $827 | $34 |
| Metoprolol | 30 | $777 | $26 |
| Rosuvastatin | 33 | $714 | $22 |
| Benazepril | 15 | $476 | $32 |
| Metformin | 46 | $423 | $9 |
| Gabapentin | 21 | $383 | $18 |
| Pantoprazole | 18 | $378 | $21 |
| Hydrochlorothiazide | 38 | $326 | $9 |
| Enalapril Maleate | 14 | $272 | $19 |
| Pravastatin | 11 | $260 | $24 |
| Alendronate | 22 | $211 | $10 |
| Tamsulosin | 24 | $208 | $9 |
| Famotidine | 17 | $198 | $12 |
| Fluticasone Propionate | 13 | $181 | $14 |
| Carvedilol | 11 | $178 | $16 |
| Simvastatin | 13 | $166 | $13 |
| Metformin Hcl Er | 11 | $159 | $14 |
| Alcohol Prep Pads | 11 | $153 | $14 |
| Cyclobenzaprine | 16 | $150 | $9 |
| Omeprazole | 17 | $105 | $6 |
| Furosemide | 13 | $102 | $8 |
| Escitalopram | 14 | $101 | $7 |
| Azithromycin | 19 | $95 | $5 |
| Methylprednisolone | 11 | $83 | $8 |
| Naproxen | 15 | $70 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $70 | $6 |
| Meclizine | 11 | $52 | $5 |
| Vitamin D2 | 15 | $38 | $3 |
| Alprazolam | 11 | $22 | $2 |
2022: 2 drugs
| Levothyroxine | 12 | $143 | $12 |
| Atorvastatin | 15 | $122 | $8 |
Money from drug and device companies
$130 in 2025
| 2025 | 5 | 6 | None | $130 |
| 2024 | 6 | 7 | None | $217 |
| 2023 | 10 | 16 | None | $377 |
| 2022 | 2 | 2 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Rybelsus | $42 | 2 payments
|
| Exact Sciences | The Cologuard Plus Collection Kit | $28 | 1 payment
|
| GlaxoSmithKline | Shingrix | $22 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $22 | 1 payment
|
| Medtronic | Minimed 780g | $16 | 1 payment
|
See all 6 published payments
| Medtronic | Meals · 2025-11-26 | Minimed 780g | $16 |
| Exact Sciences | Meals · 2025-11-20 | The Cologuard Plus Collection Kit | $28 |
| Novo Nordisk | Meals · 2025-11-14 | Wegovy | $18 |
| GlaxoSmithKline | Meals · 2025-09-29 | Shingrix | $22 |
| Xeris Pharmaceuticals | Meals · 2025-09-17 | Gvoke Hypopen | $22 |
| Novo Nordisk | Meals · 2025-08-08 | Rybelsus | $24 |
See earlier years (2024, 2023, 2022)
2024: $217
| Xeris Pharmaceuticals | Gvoke Hypopen | $71 | 1 payment
|
| Lilly USA | Mounjaro | $47 | 2 payments
|
| Amgen | Otezla | $34 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $30 | 1 payment
|
| CeQur | Cequr Simplicity | $19 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $15 | 1 payment
|
2023: $377
| Exact Sciences | Cologuard Collection Kit | $66 | 3 payments
|
| Lilly USA | Mounjaro | $65 | 3 payments
|
| Pfizer | Prevnar 20 | $54 | 2 payments
|
| Averitas Pharma | Qutenza | $53 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $37 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $25 | 1 payment
|
| Amgen | Otezla | $23 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $19 | 1 payment
|
| Merck Sharp & Dohme | Pneumovax 23 | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $16 | 1 payment
|
2022: $44
| Lilly USA | Emgality | $25 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $19 | 1 payment
|
Professional record
- NPI
- 1285298810
- Licence
- NY 317591
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 1110 Eastern Pkwy, Brooklyn, NY, 11213
- NPI first listed
- 2019-04-29
- NPI last updated
- 2022-11-09
- NPI record certified
- 2022-11-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 128 Belwood Ln, Los Gatos, CA, 95032